The effect of GSK-3β in arsenic-induced apoptosis of malignant tumor cells: a systematic review and meta-analysis

References

• Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. 2004. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol. 287(4):C817–33.
   PubMed Web of Science ®Google Scholar
• Chen P, Wu JY, Huang HF, Chen YZ. 2014. The effect to IL-3Ralpha, downstream PI3k/Akt signaling of all-trans retinoic acid and arsenic trioxide in NB4 cells. Pharmazie. 69(4):297–300.
   PubMed Web of Science ®Google Scholar
• Chen P, Zhan W, Wang B, You P, Jin Q, Hou D, Wang X, et al. 2019. Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells. Exp Cell Res. 376(2):114–123.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Huang CH, Shi YJ, Lee YC, Wang LJ, Chang LS. 2018. The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells. Toxicol Appl Pharmacol. 358:43–55.
   PubMed Web of Science ®Google Scholar
• Deng L, Yuling L, Dan W. 2019a. Ginsenoside Rb1 inhibits arsenic sulfide-induced neuronal PC12 toxicity through the AKT/GSK-3β/NFAT pathway. Chin J Arteriosclerosis. 27:667–673.
   Google Scholar
• Deng S, Dai G, Chen S, Nie Z, Zhou J, Fang H, Peng H. 2019b. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway. Biomed Pharmacother. 110:602–608.
   PubMed Web of Science ®Google Scholar
• Finnegan PM, Chen W. 2012. Arsenic toxicity: the effects on plant metabolism. Front Physiol. 3:182.
   PubMed Web of Science ®Google Scholar
• Gao YH, Zhang HP, Yang SM, Yang Y, Ma YY, Zhang XY, Yang YM. 2014. Inactivation of Akt by arsenic trioxide induces cell death via mitochondrial-mediated apoptotic signaling in SGC-7901 human gastric cancer cells. Oncol Rep. 31(4):1645–1652.
   PubMed Web of Science ®Google Scholar
• Guo W, Liu J, Jian J, Li J, Wan Y, Huang C. 2014. IKK-β/NF-κB p65 mediates p27(Kip1) protein degradation in arsenite response. Biochem Biophys Res Commun. 447(4):563–568.
   PubMed Web of Science ®Google Scholar
• Heuser M, Ofran Y, Boissel N, Brunet MS, Craddock C, Janssen J, Wierzbowska A, Buske C. 2020. Acute myeloid leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 31(6):697–712.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ. 327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Hossain K, Akhand AA, Kawamoto Y, Du J, Takeda K, Wu J, Yoshihara M, Tsuboi H, Kato M, Suzuki H, et al. 2003. Caspase activation is accelerated by the inhibition of arsenite-induced, membrane rafts-dependent Akt activation. Free Radic Biol Med. 34(5):598–606.
   PubMed Web of Science ®Google Scholar
• Huang CH, Lee YC, Chiou JT, Shi YJ, Wang LJ, Chang LS. 2020. Arsenic trioxide-induced P38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells. Toxicol Appl Pharmacol. 397:115013.
   PubMed Web of Science ®Google Scholar
• Huang HS, Liu ZM, Cheng YL. 2011. Involvement of glycogen synthase kinase-3β in arsenic trioxide-induced P21 expression. Toxicol Sci. 121(1):101–109.
   PubMed Web of Science ®Google Scholar
• Huang W, Zeng YC. 2019. A candidate for lung cancer treatment: arsenic trioxide. Clin Transl Oncol. 21(9):1115–1126.
   PubMed Web of Science ®Google Scholar
• Jin J. HHT combined with As2O3 can synergistically kill U937 cells co-cultured with bone marrow stromal HS-5 cells and its mechanism. Fujian Medical University. 2016.
   Google Scholar
• Liang J, Slingerland JM. 2003. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle. 2(4):339–345.
   PubMed Web of Science ®Google Scholar
• Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessig TA, Bouchard RJ, Florez-McClure ML, Heidenreich KA. 2004. Glycogen synthase kinase-3beta phosphorylates bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci. 24(44):9993–10002.
   PubMed Web of Science ®Google Scholar
• Lo RK, Kwong YL. 2014. Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1. Ann Hematol. 93(2):255–265.
   PubMed Web of Science ®Google Scholar
• Luo H, Song B, Xiong G, Zhang B, Zuo Z, Zhou Z, Chang X. 2021. Cadmium inhibits neural stem/progenitor cells proliferation via MitoROS-dependent AKT/GSK-3β/β-catenin signaling pathway. J Appl Toxicol. 41(12):1998–2010.
   PubMed Web of Science ®Google Scholar
• Meijer L, Flajolet M, Greengard P. 2004. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci. 25(9):471–480.
   PubMed Web of Science ®Google Scholar
• Miltonprabu S, Sumedha NC, Senthilraja P. 2017. Diallyl trisulfide, a garlic polysulfide protects against as-induced renal oxidative nephrotoxicity, apoptosis and inflammation in rats by activating the Nrf2/ARE signaling pathway. Int Immunopharmacol. 50:107–120.
   PubMed Web of Science ®Google Scholar
• Niu C, Yan H, Yu T, Sun HP, Liu JX, Li XS, Wu W, Zhang FQ, Chen Y, Zhou L, et al. 1999. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood. 94(10):3315–3324.
   PubMed Web of Science ®Google Scholar
• Park S, Han H-T, Oh S-S, Kim DH, Jeong J-W, Lee KW, Kim M, Lim JS, Cho YY, Hwangbo C, et al. 2019. NDRG2 sensitizes myeloid leukemia to arsenic trioxide via GSK3β-NDRG2-PP2A complex formation. Cells. 8(5):495.
   Web of Science ®Google Scholar
• Sahin I, Eturi A, De Souza A, Pamarthy S, Tavora F, Giles FJ, Carneiro BA. 2019. Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses. Cancer Biol Ther. 20(8):1047–1056.
   PubMed Web of Science ®Google Scholar
• Swindell EP, Hankins PL, Chen H, Miodragović DU, O'Halloran TV. 2013. Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes. Inorg Chem. 52(21):12292–12304.
   PubMed Web of Science ®Google Scholar
• Tan Z, Kang T, Zhang X, Tong Y, Chen S. 2019. Nerve growth factor prevents arsenic-induced toxicity in PC12 cells through the AKT/GSK-3β/NFAT pathway. J Cell Physiol. 234(4):4726–4738.
   PubMed Web of Science ®Google Scholar
• Vidri RJ, Fitzgerald TL. 2020. GSK-3: an important kinase in colon and pancreatic cancers. Biochim Biophys Acta Mol Cell Res. 1867(4):118626.
   PubMed Web of Science ®Google Scholar
• Wang R, Xia L, Gabrilove J, Waxman S, Jing Y. 2013. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells. Leukemia. 27(2):315–324.
   PubMed Web of Science ®Google Scholar
• Wang R, Li Y, Gong P, Gabrilove J, Waxman S, Jing Y. 2018. Arsenic trioxide and sorafenib induce synthetic lethality of FLT3-ITD acute myeloid leukemia cells. Mol Cancer Ther. 17(9):1871–1880.
   PubMed Web of Science ®Google Scholar
• Watcharasit P, Thiantanawat A, Satayavivad J. 2008. GSK3 promotes arsenite-induced apoptosis via facilitation of mitochondria disruption. J Appl Toxicol. 28(4):466–474.
   PubMed Web of Science ®Google Scholar
• Wen SY, Chen YY, Deng CM, Zhang CQ, Jiang MM. 2019. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway. Phytomedicine. 57:352–363.
   PubMed Web of Science ®Google Scholar
• Xie Y, Shi X, Sheng K, Han G, Li W, Zhao Q, Jiang B, Feng J, Li J, Gu Y. 2019. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review). Mol Med Rep. 19(2):783–791.
   PubMed Web of Science ®Google Scholar
• Yang K, Chen Z, Gao J, Shi W, Li L, Jiang S, Hu H, Liu Z, Xu D, Wu L. 2017. The key roles of GSK-3β in regulating mitochondrial activity. Cell Physiol Biochem. 44(4):1445–1459.
   PubMedGoogle Scholar
• You Peidong. The Mcl-1 gene plays an important role in HHT and ATO to significantly kill HL60 cells co-cultured with bone marrow stromal HS-5 cells. Fujian Medical University. 2017.
   Google Scholar
• Zhai B, Jiang X, He C, Zhao D, Ma L, Xu L, Jiang H, Sun X. 2015. Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation. Tumour Biol. 36(4):2323–2334.
   PubMedGoogle Scholar
• Zheng L, Jiang H, Zhang ZW, Wang KN, Wang QF, Li QL, Jiang T. 2016. Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cells. Onco Targets Ther. 9:885–894.
   PubMed Web of Science ®Google Scholar
• Zhong L, Xu F, Chen F. 2018. Arsenic trioxide induces the apoptosis and decreases NF-κB expression in lymphoma cell lines. Oncol Lett. 16(5):6267–6274.
   PubMed Web of Science ®Google Scholar